Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 811.27B | 811.27B | 706.66B | 708.69B | 716.41B | 733.85B |
Gross Profit | 247.19B | 247.19B | 214.51B | 212.46B | 216.27B | 222.04B |
EBITDA | 19.67B | 24.54B | 18.55B | 18.18B | 23.65B | 28.02B |
Net Income | 810.00M | 810.00M | 1.01B | 1.34B | 5.37B | 8.85B |
Balance Sheet | ||||||
Total Assets | 382.60B | 382.60B | 285.50B | 278.73B | 280.74B | 285.09B |
Cash, Cash Equivalents and Short-Term Investments | 35.74B | 35.74B | 21.14B | 25.63B | 32.50B | 38.12B |
Total Debt | 63.13B | 63.13B | 44.84B | 42.77B | 39.83B | 35.00B |
Total Liabilities | 179.27B | 179.27B | 135.26B | 128.71B | 128.50B | 136.29B |
Stockholders Equity | 203.33B | 203.33B | 150.25B | 150.02B | 151.68B | 148.34B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -8.19B | -2.37B | -5.32B | -8.47B | 12.91B |
Operating Cash Flow | 0.00 | 14.48B | 21.50B | 15.21B | 16.02B | 29.92B |
Investing Cash Flow | 0.00 | -16.26B | -25.55B | -22.80B | -24.32B | -15.94B |
Financing Cash Flow | 0.00 | 6.94B | -442.00M | 495.00M | 2.39B | 4.14B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
71 Outperform | ¥151.44B | 10.45 | 2.39% | 6.05% | 22.72% | ||
62 Neutral | ¥188.96B | 187.65 | 1.67% | 23.04% | ― | ||
61 Neutral | $17.96B | 13.14 | -5.29% | 3.00% | 1.25% | -13.95% | |
― | $1.22B | 15.45 | 7.98% | ― | ― | ― | |
68 Neutral | ¥232.52B | 19.36 | 2.81% | 18.53% | -36.19% | ||
65 Neutral | ¥129.33B | 39.67 | 1.73% | 7.54% | -47.00% | ||
61 Neutral | ¥175.36B | 35.97 | 1.49% | 1.54% | -15.67% |